Papers

2

Total Citations

28

H-Index

2

About

No biography available yet.

Research Focus

Key Achievements

2
H-Index
2
Papers
28
Total Citations
14
Avg Citations/Paper
🏆 Most Cited Paper
Surgical outcomes after chemotherapy plus nivolumab and chemotherapy plus nivolumab and ipilimumab in patients with non–small cell lung cancer
19 citations · 2023
📈 Most Prolific Year: 2023 (2 Papers)
🤝 Key Collaborators: 23
🏛 Institutions: The University of Texas MD Anderson Cancer Center

Top Papers

  1. 1
  2. 2

Key Collaborators

Not generated yet